- cafead   Sep 06, 2023 at 10:12: AM
via Less than one year after selling an experimental medicine to Takeda for $4 billion, Nimbus Therapeutics is reloading with new funding meant to support its next wave of drug candidates, among them a prospective cancer therapy.
article source
article source